Kambiz Rahbar

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

Oliver Sartor, Johann S. de Bono, Kim N. et al. · New England Journal of Medicine · 2021 · 2.3K citations · Full text

German Multicenter Study Investigating¹⁷⁷Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar, Hojjat Ahmadzadehfar, Clemens Kratochwil et al. · Journal of Nuclear Medicine · 2016 · 812 citations · Full text

EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT)

Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 368 citations

Eanm Procedure Guidelines, Engineering, Radiation Therapy +12

Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study

Hojjat Ahmadzadehfar, Kambiz Rahbar, Stefan Kürpig et al. · EJNMMI Research · 2015 · 289 citations · Full text

Differentiation of Malignant and Benign Cardiac Tumors Using ¹⁸F-FDG PET/CT

Kambiz Rahbar, Harald Seifarth, Michael Schäfers et al. · Journal of Nuclear Medicine · 2012 · 262 citations · Full text